Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-effectiveness Analysis
2
Zitationen
12
Autoren
2025
Jahr
Abstract
OBJECTIVE: The increasing incidence of thyroid nodules (TNs) raises concerns about overdiagnosis and overtreatment. This study evaluates the clinical and economic impact of KOIOS, a Food and Drug Administration-approved artificial intelligence (AI) tool for the management of TN. METHODS: A retrospective analysis was conducted on 176 patients who underwent thyroid surgery between May 2022 and November 2024. Ultrasound images were evaluated independently by an expert and novice operators using the American College of Radiology Thyroid Imaging Reporting and Data System, while KOIOS provided AI-adapted risk stratification. Sensitivity, specificity, and receiver operating (ROC) curve analysis were performed. The incremental cost-effectiveness ratio (ICER) was defined based on the number of optimal care interventions (fine-needle aspiration biopsies and thyroid surgeries). Both deterministic and probabilistic sensitivity analyses were conducted to evaluate model robustness. RESULTS: KOIOS AI demonstrated similar diagnostic performance to the expert operator [area under the curve (AUC): 0.794, 95% confidence interval (CI): 0.718-0.871 vs 0.784, 95% CI: 0.706-0.861; P = .754] and significantly outperformed the novice operator (AUC: 0.619, 95% CI: 0.526-0.711; P < .001). ICER analysis estimated the cost per additional optimal care decision at -€8085.56, indicating KOIOS as a dominant and cost-saving strategy when considering a third-party payer perspective over a 1-year horizon. Deterministic sensitivity analysis identified surgical costs as the main drivers of variability, while probabilistic analysis consistently favored KOIOS as the optimal strategy. CONCLUSION: KOIOS AI is a cost-effective alternative, particularly in reducing overdiagnosis and overtreatment for benign TNs. Prospective, real-life studies are needed to validate these findings and explore long-term implications.
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.265 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.735 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.857 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.358 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.044 Zit.
Autoren
Institutionen
- Hospital Universitari de Tortosa Verge de la Cinta(ES)
- Universitat Rovira i Virgili(ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol(ES)
- Institut Català de la Salut(ES)
- Universitat de València(ES)
- Instituto de Salud Carlos III(ES)
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas(ES)
- Hospital Clínico Universitario de Valencia(ES)
- Hospital General Universitari de Castelló(ES)
- Hospital de Sant Pau(ES)
- Health Research Institute of the Balearic Islands(ES)
- Hospital Universitario Son Espases(ES)
- Universitat de les Illes Balears(ES)